Long-horizon patient capital is linked to stronger high-quality growth in China's strategic emerging industries, working through digital–green transformation, better information, and easier financing; the payoff is larger for firms that adopt AI and varies markedly by region and industry.

Main Finding

Patient capital (long-horizon, value-oriented equity and relationship-based debt) significantly promotes the high-quality development of Chinese firms in strategic emerging industries (sample: 743 listed firms, 2014–2023). It works through three channels—enhancing digital–green transformation synergy, reducing information asymmetry, and easing financing constraints—and the positive effect is strengthened by firms’ application of artificial intelligence (AI). Effects vary by region and sub-industry: central-region firms are most responsive, and stable equity vs relationship-based debt differ in effectiveness across specific emerging sectors.

Key Points

• Core result: Patient capital → higher firm-level high-quality development (HQD).
• Mechanisms:
  • Digital–green transformation synergy (DGS): patient capital supports long‑horizon investments that integrate digital tech and green practices, raising productivity and sustainability.
  • Information asymmetry (ASY): patient investors’ long-term engagement and expertise reduce information gaps and adverse selection.
  • Financing constraints (FC): patient capital provides stable funding and market signaling that relax financing bottlenecks for long‑cycle innovation.
• Moderation: Higher levels of firm AI application amplify the positive effect of patient capital on HQD.
• Heterogeneity:
  • Regional: strongest impact in the central region; weaker marginal effects in the east (more diversified finance) and west (weaker absorptive capacity/institutional environment).
  • Sub-industry: patient capital (both stable equity and relationship-based debt) most effective in new energy vehicles, energy conservation & environmental protection, biotechnology, new materials, and next‑generation information technology. Stable equity shows particularly strong effects in high‑end equipment manufacturing and new energy sectors compared with relationship-based debt.
• Contributions: extends patient-capital literature to strategic emerging industries; identifies digital–green synergy, ASY, and FC as mediating channels; positions AI adoption as a key moderator.

Data & Methods

• Data: Panel of 743 China-listed firms classified in strategic emerging industries, covering 2014–2023.
• Dependent variable: firm-level high-quality development index (HQD).
• Key independent variables: patient capital proxies—Equity (stable equity holdings) and Debt (relationship-based debt).
• Mediators: indices/proxies for digital–green transformation synergy (DGS), information asymmetry (ASY), and financing constraints (FC).
• Moderator: firm-level AI application intensity.
• Empirical approach:
  • Baseline regressions with firm (industry) and year fixed effects to estimate the effect of patient capital on HQD.
  • Mediation testing following a two‑step procedure (estimate effect of patient capital on mediators, then mediators on HQD).
  • Moderation tested via interaction terms (PatientCapital × AI).
  • Heterogeneity analyses across regions (east/central/west) and sub-industries; robustness checks reported.
• Identification / limitations (as presented): fixed-effects panel controls and multiple robustness analyses; paper does not claim randomized identification—residual endogeneity concerns and measurement choices remain possible limitations.

Implications for AI Economics

• Complementarity between AI and long-horizon finance: AI adoption reduces innovation uncertainty and improves resource allocation, increasing expected returns to patient capital. Models of AI-driven growth should incorporate financing regime effects (long-term vs short-term finance) as modifiers of AI adoption payoffs.
• AI as a mechanism to lower information frictions: empirical evidence suggests AI both (a) magnifies the governance/monitoring value of patient investors and (b) can be modeled as an information-production technology that changes investors’ incentives and risk sharing.
• Policy design: to maximize societal returns from AI and green/digital transitions, policies should:
  • Encourage patient-capital vehicles (stable equity funds, relationship-based debt structures) targeted to AI‑intensive emerging sectors.
  • Promote AI diffusion in firms to unlock complementary investment from patient capital.
  • Use regionally tailored approaches—central regions may yield larger marginal returns to patient-capital policies than mature eastern regions or capacity-constrained western areas.
• Corporate finance and investor strategy:
  • Patient-capital providers should prioritize AI-capable firms because AI increases the effectiveness of long-horizon investments.
  • Investors and policymakers evaluating industrial policy for AI should account for the role of patient capital in alleviating financing frictions for long-cycle AI commercialization.
• Research directions for AI economics:
  • Quantify how AI adoption changes the risk-return profile of long-term investments and the demand for patient capital.
  • Causal identification of the interaction (e.g., instrumenting patient capital or leveraging policy shocks to patient-capital supply).
  • Cross-country comparisons to test external validity where financial systems and AI ecosystems differ.

Reference: Ji, F.-f., & Zhang, M. (2026). The Impact of Patient Capital on the High-Quality Development of Enterprises in Strategic Emerging Industries. Journal of Risk Analysis and Crisis Response, 16(1), 43–62. DOI: https://doi.org/10.54560/jracr.v16i1.844